Didier Hober

researcher

Born 1961-01-01

Didier Hober is …
instance of (P31):
humanQ5

External links are
P269IdRef ID078241774
P213ISNI0000000140161739
P496ORCID iD0000-0002-4301-2074
P214VIAF cluster ID199914238

P184doctoral advisorAndré CapronQ517594
P185doctoral studentWassim ChehadehQ39190421
Famara SaneQ56380428
Rachel DesailloudQ60393992
P735given nameDidierQ17978544
DidierQ17978544
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

doctoral advisor (P184)
Q56380428Famara Sane
Q60393992Rachel Desailloud
Q39190421Wassim Chehadeh

author (P50)
Q39439105(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
Q36350555A microfluidic device for on-chip agarose microbead generation with ultralow reagent consumption
Q104691514A real-time quantitative PCR targeting the viral vector for the monitoring of patients treated with axicabtagene ciloleucel
Q26801423Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks
Q39238492Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.
Q40698192Antibodies to VP1 of swine pasivirus in humans without evidence of transmission from a pig source.
Q38849484Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology
Q64360304Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro
Q40166957Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro
Q40531437Central nervous system infection following vertical transmission of Coxsackievirus B4 in mice.
Q42269037Clinically severe Epstein-Barr virus encephalitis with mild cerebrospinal fluid abnormalities in an immunocompetent adolescent: a case report.
Q49793532Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMV.
Q52685431Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV.
Q24601560Confronting potential influenza A (H5N1) pandemic with better vaccines
Q40326290Correlation between the anti-virus-induced cytopathic effect activity of interferon-alpha subtypes and induction of MxA protein in vitro
Q40893867Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived Macrophages
Q39138391Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates.
Q37492730Coxsackievirus B4 infection of human fetal thymus cells
Q98943348Coxsackievirus-B4 Infection Can Induce the Expression of Human Endogenous Retrovirus W in Primary Cells
Q91587686Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells
Q38172343Decoding norovirus infection in Crohn's disease
Q42248756Detection of hepatitis B virus infection markers in dried plasma spots among patients in Congo-Brazzaville.
Q57187160Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice
Q50071646Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM.
Q41391190Diagnosis of viral infections using myxovirus resistance protein A (MxA).
Q90331205Does control of glycemia regulate immunological parameters in insulin-treated persons with type 1 diabetes?
Q95317637Donor-to-recipient transmission and reactivation in a kidney transplant recipient of an inherited chromosomally integrated HHV-6A: Evidence and outcomes
Q92376577Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4
Q89968776Enhancing and neutralizing anti-coxsackievirus activities in serum samples from patients prior to development of type 1 diabetes
Q97412249Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells
Q36550190Enteroviral central nervous system infections in children of the region of monastir, Tunisia: diagnosis, laboratory findings of cerebrospinal fluid and clinical manifestations
Q37784271Enteroviral pathogenesis of type 1 diabetes.
Q38095342Enteroviral pathogenesis of type 1 diabetes: queries and answers
Q40070182Enterovirus D68 detection in respiratory specimens: Association with severe disease
Q27008445Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes
Q99725238Enteroviruses and Type 1 Diabetes Mellitus: An Overlooked Relationship in Some Regions
Q37772438Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.
Q38693613Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR.
Q40063941Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.
Q92499498Evaluation of the reverse transcription strand invasion based amplification (RT-SIBA) RSV assay, a rapid molecular assay for the detection of respiratory syncytial virus
Q40519596Exposure of Piglets to Enteroviruses Investigated by an Immunoassay Based on the EV-G1 VP4 Peptide.
Q108832228Fluoxetine Can Inhibit SARS-CoV-2 In Vitro
Q57043668Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo
Q37877267Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
Q39822069Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene.
Q40740639High Efficiency of Functional Carbon Nanodots as Entry Inhibitors of Herpes Simplex Virus Type 1.
Q42200424Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors.
Q26801632How Does Thymus Infection by Coxsackievirus Contribute to the Pathogenesis of Type 1 Diabetes?
Q37262868Immunoglobulin G-dependent enhancement of the infection with Coxsackievirus B4 in a murine system
Q91841227Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation
Q36267534In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients
Q34669019Inactivation of an enterovirus by airborne disinfectants
Q54541397Infection of primary cultures of murine splenic and thymic cells with coxsackievirus B4.
Q54240361Inhibition of coxsackievirus B4 by Lactobacillus plantarum
Q40118654Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.
Q34017276Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases
Q40799874Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA.
Q39141892Necessity to critically review the automatic results of the Xpert Flu assay
Q35914270New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.
Q91304858Paediatric enterovirus meningitis without cerebrospinal fluid pleocytosis
Q92575062Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity
Q37721131Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host
Q38732011Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.
Q33418888Persistent infection of a carcinoma thyroid cell line with coxsackievirus B.
Q34043114Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine.
Q39683493Persistent infection of human thymic epithelial cells by coxsackievirus B4.
Q36276241Persistent infection of thymic epithelial cells with coxsackievirus B4 results in decreased expression of type 2 insulin-like growth factor
Q38153686Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity
Q48624680Prolonged viral RNA detection in the central nervous system of one-week-old Swiss albino mice following coxsackievirus B4 and echovirus 9 infection
Q88413413Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl
Q89566024Repeated viral meningitis in a newborn
Q38725613Resistance of Enteric Viruses on Fomites.
Q91211257Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay
Q59360832Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study
Q42244449Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells
Q59353109Serum-derived IgG from coxsackievirus A6-infected patients can enhance the infection of peripheral blood mononuclear cells with coxsackievirus A6
Q40725588Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation
Q37740399Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes
Q38902114Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.
Q34123873Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon
Q45324856Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.
Q37126267Viruses and thyroiditis: an update
Q90937254miRNAs in enterovirus infection

Q517594André Caprondoctoral studentP185

Search more.